{"DataElement":{"publicId":"5999741","version":"1","preferredName":"Bladder Cancer AJCC Edition 8 Clinical Regional Lymph Node N Category","preferredDefinition":"Extent of the regional lymph node involvement for bladder urothelial carcinoma based on evidence obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed. 8 criteria.","longName":"BLAD_AJC8_CLN_N_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2190135","version":"1","preferredName":"Bladder Tumor Clinical N Stage","preferredDefinition":"Information related to the clinical N stage of a bladder tumor.","longName":"BLAD_TUMOR_C_N","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6D30CC4-8BD0-3402-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-19","modifiedBy":"TAYLORT","dateModified":"2018-11-28","changeDescription":"10/9/17 tt transferred context/BC; added Reg Status.  Updated to use Property based on NCIt concept","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6569750","version":"1","preferredName":"Bladder Carcinoma American Joint Committee on Cancer Edition 8 N Category","preferredDefinition":"A finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this classification system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._A grouping of items based on some commonality or by user defined characteristics.","longName":"6569750v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3","valueDescription":"Bladder Cancer pN3 TNM Finding v8","ValueMeaning":{"publicId":"6569752","version":"1","preferredName":"Bladder Cancer pN3 TNM Finding v8","longName":"6569752","preferredDefinition":"Bladder cancer with lymph node metastasis to the common iliac lymph nodes. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pN3 TNM Finding v8","conceptCode":"C140412","definition":"Bladder cancer with lymph node metastasis to the common iliac lymph nodes. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACFC4A-B452-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACFC4A-B46B-3F63-E053-F662850A9BAE","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"N2","valueDescription":"Bladder Cancer pN2 TNM Finding v8","ValueMeaning":{"publicId":"6569754","version":"1","preferredName":"Bladder Cancer pN2 TNM Finding v8","longName":"6569754","preferredDefinition":"Bladder cancer with multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pN2 TNM Finding v8","conceptCode":"C140411","definition":"Bladder cancer with multiple regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node metastasis). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACFC4A-B478-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACFC4A-B491-3F63-E053-F662850A9BAE","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"N1","valueDescription":"Bladder Cancer pN1 TNM Finding v8","ValueMeaning":{"publicId":"6569756","version":"1","preferredName":"Bladder Cancer pN1 TNM Finding v8","longName":"6569756","preferredDefinition":"Bladder cancer with single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pN1 TNM Finding v8","conceptCode":"C140410","definition":"Bladder cancer with single regional lymph node metastasis in the true pelvis (perivesical, obturator, internal and external iliac, or sacral lymph node). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACFC4A-B49E-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACFC4A-B4B7-3F63-E053-F662850A9BAE","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"N0","valueDescription":"Bladder Cancer pN0 TNM Finding v8","ValueMeaning":{"publicId":"6569758","version":"1","preferredName":"Bladder Cancer pN0 TNM Finding v8","longName":"6569758","preferredDefinition":"Bladder cancer with no lymph node metastasis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pN0 TNM Finding v8","conceptCode":"C140409","definition":"Bladder cancer with no lymph node metastasis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACFC4A-B4C4-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACFC4A-B4DD-3F63-E053-F662850A9BAE","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"},{"value":"NX","valueDescription":"Bladder Cancer pNX TNM Finding v8","ValueMeaning":{"publicId":"6569760","version":"1","preferredName":"Bladder Cancer pNX TNM Finding v8","longName":"6569760","preferredDefinition":"Bladder cancer in which the lymph nodes cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer pNX TNM Finding v8","conceptCode":"C140408","definition":"Bladder cancer in which the lymph nodes cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACFC4A-B4EA-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7BACFC4A-B503-3F63-E053-F662850A9BAE","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6569749","version":"1","preferredName":"Bladder Cancer TNM Finding v8 American Joint Committee on Cancer N Category Category","preferredDefinition":"A finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this classification system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C140380:C39315:C25580:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer TNM Finding v8","conceptCode":"C140380","definition":"A finding about one or more characteristics of bladder cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to carcinomas arising in the bladder. The typical carcinoma of the bladder is urothelial carcinoma. These carcinomas may include other histologic elements, including adenocarcinoma, squamous cell carcinoma, and small cell neuroendocrine carcinoma, but should be classified as urothelial unless the cancer is composed entirely of the alternative histology. All histologic cell types that are derived primarily from the urinary bladder epithelium should follow this classification system. It does not apply to prostatic urothelial carcinomas (are staged according to the classification for urethra), lymphomas (are staged according to the classification for Hodgkin and non-Hodgkin lymphoma), and sarcomas (are staged according to the classification for soft tissue sarcoma of the abdomen and thoracic visceral organs).  (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BACFC4A-B425-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"ONEDATA","dateModified":"2018-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"7BACFC4A-B436-3F63-E053-F662850A9BAE","latestVersionIndicator":"Yes","beginDate":"2018-11-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-11-27","modifiedBy":"TAYLORT","dateModified":"2019-09-03","changeDescription":"8-20-19 released per MC.; 11-27-18 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000515","version":"1","longName":"Bladder","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical N category","type":"Preferred Question Text","description":"Clinical N category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5B235D0C-9E26-5EDD-E053-F662850AF395","latestVersionIndicator":"Yes","beginDate":"2017-10-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-09","modifiedBy":"TAYLORT","dateModified":"2019-08-30","changeDescription":"8-30-19 TMT released per MC.; 11/28/2018 TMT updated content. 10/9/17  tt Created for standard harmonization. Incomplete pending updates to VD per NCIt Ed 8 caDSR concept loading; supercedes CDE 3361877.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}